| Role |
Name |
Disclosure |
Details |
| Author | Carol Vandenakker-Albanese, MD, Director, Post-Polio Clinic, Department of Physical Medicine and Rehabilitation, University of California at Davis Health System; Physical Medicine and Rehabilitation Residency Director, University of California at Davis | Nothing to disclose | Details | | Coauthor | Holly Zhao, MD, PhD, Assistant Professor of Clinical Physical Medicine and Rehabilitation, University of California Davis Health System | Nothing to disclose | Details | | Medical Editor | Elizabeth A Moberg-Wolff, MD, Associate Professor and Pediatric PM&R Fellowship Director, Department of Physical Medicine and Rehabilitation, Medical College of Wisconsin; Program Director, Tone Management and Mobility, Department of Physical Medicine and Rehabilitation, Children's Hospital of Wisconsin | Medtronic Neurological | Details | | Pharmacy Editor | Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine | Nothing to disclose | Details | | Managing Editor | Michael T Andary, MD, MS, Residency Program Director, Professor, Department of Physical Medicine and Rehabilitation, Michigan State University College of Osteopathic Medicine | allergan | Details | | CME Editor | Kelly L Allen, MD, Consulting Staff, Department of Physical Medicine and Rehabilitation, Lourdes Regional Rehabilitation Center, Our Lady of Lourdes Medical Center | Nothing to disclose | Details | | Chief Editor | Denise I Campagnolo, MD, MS, Director of Multiple Sclerosis Clinical Research and Staff Physiatrist, Barrow Neurology Clinics, St. Joseph's Hospital and Medical Center; Investigator for Barrow Neurology Clinics; Director, NARCOMS Project for Consort | Teva Neuroscience Serono-Pfizer | Details |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Holly Zhao, Coauthor |
The contributor discloses no conflict of interest. |
|